ASX - By Stock
|
AN1 |
Re:
Ann: Appendix 4C and Quarterly Activity Report
|
|
Pharmargeddon
|
12 |
3.3K |
0 |
29/10/22 |
29/10/22 |
ASX - By Stock
|
12
|
3.3K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Roquefort/Lyramid postings
|
|
Pharmargeddon
|
186 |
43K |
0 |
26/10/22 |
26/10/22 |
ASX - By Stock
|
186
|
43K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Annual Report to shareholders
|
|
Pharmargeddon
|
8 |
2.9K |
1 |
18/10/22 |
18/10/22 |
ASX - By Stock
|
8
|
2.9K
|
1
|
|
ASX - By Stock
|
AN1 |
Re:
Roquefort/Lyramid postings
|
|
Pharmargeddon
|
186 |
43K |
2 |
13/10/22 |
13/10/22 |
ASX - By Stock
|
186
|
43K
|
2
|
|
ASX - By Stock
|
AN1 |
Re:
Roquefort/Lyramid postings
|
|
Pharmargeddon
|
186 |
43K |
4 |
13/10/22 |
13/10/22 |
ASX - By Stock
|
186
|
43K
|
4
|
|
ASX - By Stock
|
AN1 |
Re:
Roquefort/Lyramid postings
|
|
Pharmargeddon
|
186 |
43K |
3 |
12/10/22 |
12/10/22 |
ASX - By Stock
|
186
|
43K
|
3
|
|
ASX - By Stock
|
AN1 |
Re:
Roquefort/Lyramid postings
|
|
Pharmargeddon
|
186 |
43K |
1 |
10/10/22 |
10/10/22 |
ASX - By Stock
|
186
|
43K
|
1
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Annual Report to shareholders
|
|
Pharmargeddon
|
8 |
2.9K |
3 |
05/10/22 |
05/10/22 |
ASX - By Stock
|
8
|
2.9K
|
3
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Annual Report to shareholders
|
|
Pharmargeddon
|
8 |
2.9K |
3 |
03/10/22 |
03/10/22 |
ASX - By Stock
|
8
|
2.9K
|
3
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Annual Report to shareholders
|
|
Pharmargeddon
|
8 |
2.9K |
2 |
02/10/22 |
02/10/22 |
ASX - By Stock
|
8
|
2.9K
|
2
|
|
ASX - By Stock
|
AN1 |
Re:
New Product thread from old FGF5 Aptamer posting
|
|
Pharmargeddon
|
7 |
1.2K |
3 |
28/09/22 |
28/09/22 |
ASX - By Stock
|
7
|
1.2K
|
3
|
|
ASX - By Stock
|
AN1 |
Re:
New Product thread from old FGF5 Aptamer posting
|
|
Pharmargeddon
|
7 |
1.2K |
3 |
28/09/22 |
28/09/22 |
ASX - By Stock
|
7
|
1.2K
|
3
|
|
ASX - By Stock
|
AN1 |
Re:
New Product thread from old FGF5 Aptamer posting
|
|
Pharmargeddon
|
7 |
1.2K |
1 |
28/09/22 |
28/09/22 |
ASX - By Stock
|
7
|
1.2K
|
1
|
|
ASX - By Stock
|
AN1 |
Re:
New Product thread from old FGF5 Aptamer posting
|
|
Pharmargeddon
|
7 |
1.2K |
3 |
28/09/22 |
28/09/22 |
ASX - By Stock
|
7
|
1.2K
|
3
|
|
ASX - By Stock
|
AN1 |
New Product thread from old FGF5 Aptamer posting
|
|
Pharmargeddon
|
7 |
1.2K |
1 |
28/09/22 |
28/09/22 |
ASX - By Stock
|
7
|
1.2K
|
1
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Publishes Data on Novel Proprietary FGF5 Aptamer
|
|
Pharmargeddon
|
29 |
6.2K |
2 |
28/09/22 |
28/09/22 |
ASX - By Stock
|
29
|
6.2K
|
2
|
|
ASX - By Stock
|
AN1 |
Re:
Roquefort/Lyramid postings
|
|
Pharmargeddon
|
186 |
43K |
0 |
23/09/22 |
23/09/22 |
ASX - By Stock
|
186
|
43K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Roquefort/Lyramid postings
|
|
Pharmargeddon
|
186 |
43K |
1 |
21/09/22 |
21/09/22 |
ASX - By Stock
|
186
|
43K
|
1
|
|
ASX - By Stock
|
AN1 |
Re:
Roquefort/Lyramid postings
|
|
Pharmargeddon
|
186 |
43K |
0 |
19/09/22 |
19/09/22 |
ASX - By Stock
|
186
|
43K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Roquefort/Lyramid postings
|
|
Pharmargeddon
|
186 |
43K |
2 |
19/09/22 |
19/09/22 |
ASX - By Stock
|
186
|
43K
|
2
|
|
ASX - By Stock
|
AN1 |
Re:
Roquefort/Lyramid postings
|
|
Pharmargeddon
|
186 |
43K |
3 |
19/09/22 |
19/09/22 |
ASX - By Stock
|
186
|
43K
|
3
|
|
ASX - By Stock
|
AN1 |
Re:
Roquefort/Lyramid postings
|
|
Pharmargeddon
|
186 |
43K |
2 |
18/09/22 |
18/09/22 |
ASX - By Stock
|
186
|
43K
|
2
|
|
ASX - By Stock
|
AN1 |
Re:
BLC
|
|
Pharmargeddon
|
17 |
5.3K |
5 |
13/09/22 |
13/09/22 |
ASX - By Stock
|
17
|
5.3K
|
5
|
|
ASX - By Stock
|
AN1 |
Re:
BLC
|
|
Pharmargeddon
|
17 |
5.3K |
1 |
07/09/22 |
07/09/22 |
ASX - By Stock
|
17
|
5.3K
|
1
|
|
ASX - By Stock
|
AN1 |
Re:
BLC
|
|
Pharmargeddon
|
17 |
5.3K |
3 |
06/09/22 |
06/09/22 |
ASX - By Stock
|
17
|
5.3K
|
3
|
|
ASX - By Stock
|
AN1 |
Re:
BLC
|
|
Pharmargeddon
|
17 |
5.3K |
1 |
02/09/22 |
02/09/22 |
ASX - By Stock
|
17
|
5.3K
|
1
|
|
ASX - By Stock
|
AN1 |
Re:
BLC
|
|
Pharmargeddon
|
17 |
5.3K |
1 |
01/09/22 |
01/09/22 |
ASX - By Stock
|
17
|
5.3K
|
1
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Appendix 4E and FY22 Financial Report
|
|
Pharmargeddon
|
18 |
4.3K |
1 |
29/08/22 |
29/08/22 |
ASX - By Stock
|
18
|
4.3K
|
1
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Appendix 4E and FY22 Financial Report
|
|
Pharmargeddon
|
18 |
4.3K |
2 |
27/08/22 |
27/08/22 |
ASX - By Stock
|
18
|
4.3K
|
2
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Appendix 4E and FY22 Financial Report
|
|
Pharmargeddon
|
18 |
4.3K |
1 |
27/08/22 |
27/08/22 |
ASX - By Stock
|
18
|
4.3K
|
1
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Appendix 4E and FY22 Financial Report
|
|
Pharmargeddon
|
18 |
4.3K |
3 |
27/08/22 |
27/08/22 |
ASX - By Stock
|
18
|
4.3K
|
3
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Appendix 4E and FY22 Financial Report
|
|
Pharmargeddon
|
18 |
4.3K |
1 |
26/08/22 |
26/08/22 |
ASX - By Stock
|
18
|
4.3K
|
1
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Appendix 4E and FY22 Financial Report
|
|
Pharmargeddon
|
18 |
4.3K |
0 |
26/08/22 |
26/08/22 |
ASX - By Stock
|
18
|
4.3K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Appendix 4E and FY22 Financial Report
|
|
Pharmargeddon
|
18 |
4.3K |
0 |
25/08/22 |
25/08/22 |
ASX - By Stock
|
18
|
4.3K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Appendix 4E and FY22 Financial Report
|
|
Pharmargeddon
|
18 |
4.3K |
1 |
25/08/22 |
25/08/22 |
ASX - By Stock
|
18
|
4.3K
|
1
|
|
ASX - By Stock
|
AN1 |
Re:
Roquefort/Lyramid postings
|
|
Pharmargeddon
|
186 |
43K |
3 |
23/08/22 |
23/08/22 |
ASX - By Stock
|
186
|
43K
|
3
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Appendix 4C and Quarterly Activity Report
|
|
Pharmargeddon
|
46 |
9.6K |
3 |
22/08/22 |
22/08/22 |
ASX - By Stock
|
46
|
9.6K
|
3
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Appendix 4C and Quarterly Activity Report
|
|
Pharmargeddon
|
46 |
9.6K |
1 |
20/08/22 |
20/08/22 |
ASX - By Stock
|
46
|
9.6K
|
1
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Appendix 4C and Quarterly Activity Report
|
|
Pharmargeddon
|
46 |
9.6K |
0 |
20/08/22 |
20/08/22 |
ASX - By Stock
|
46
|
9.6K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Appendix 4C and Quarterly Activity Report
|
|
Pharmargeddon
|
46 |
9.6K |
0 |
20/08/22 |
20/08/22 |
ASX - By Stock
|
46
|
9.6K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Appendix 4C and Quarterly Activity Report
|
|
Pharmargeddon
|
46 |
9.6K |
2 |
20/08/22 |
20/08/22 |
ASX - By Stock
|
46
|
9.6K
|
2
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Appendix 4C and Quarterly Activity Report
|
|
Pharmargeddon
|
46 |
9.6K |
0 |
20/08/22 |
20/08/22 |
ASX - By Stock
|
46
|
9.6K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
AN1 Quarterly Trends
|
|
Pharmargeddon
|
32 |
7.5K |
3 |
17/08/22 |
17/08/22 |
ASX - By Stock
|
32
|
7.5K
|
3
|
|
ASX - By Stock
|
AN1 |
Re:
Roquefort/Lyramid postings
|
|
Pharmargeddon
|
186 |
43K |
3 |
12/08/22 |
12/08/22 |
ASX - By Stock
|
186
|
43K
|
3
|
|
ASX - By Stock
|
AN1 |
Re:
Roquefort/Lyramid postings
|
|
Pharmargeddon
|
186 |
43K |
2 |
11/08/22 |
11/08/22 |
ASX - By Stock
|
186
|
43K
|
2
|
|
ASX - By Stock
|
AN1 |
Re:
Roquefort/Lyramid postings
|
|
Pharmargeddon
|
186 |
43K |
1 |
11/08/22 |
11/08/22 |
ASX - By Stock
|
186
|
43K
|
1
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Appendix 4C and Quarterly Activity Report
|
|
Pharmargeddon
|
46 |
9.6K |
3 |
11/08/22 |
11/08/22 |
ASX - By Stock
|
46
|
9.6K
|
3
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Appendix 4C and Quarterly Activity Report
|
|
Pharmargeddon
|
46 |
9.6K |
3 |
10/08/22 |
10/08/22 |
ASX - By Stock
|
46
|
9.6K
|
3
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Appendix 4C and Quarterly Activity Report
|
|
Pharmargeddon
|
46 |
9.6K |
2 |
10/08/22 |
10/08/22 |
ASX - By Stock
|
46
|
9.6K
|
2
|
|
ASX - By Stock
|
AN1 |
Re:
Roquefort/Lyramid postings
|
|
Pharmargeddon
|
186 |
43K |
1 |
08/08/22 |
08/08/22 |
ASX - By Stock
|
186
|
43K
|
1
|
|